(Q37230379)

19 August 2017

1 reference

title

New cardiovascular biomarkers: clinical implications in patients with valvular heart disease (English)

1 reference

19 August 2017

0 references

Luis M Moura

1

1 reference

19 August 2017

Francisco Rocha-Gonçalves

2

1 reference

19 August 2017

José L Zamorano

3

1 reference

19 August 2017

Isabel Barros

4

1 reference

19 August 2017

Paulo Bettencourt

5

1 reference

19 August 2017

Nalini Rajamannan

6

1 reference

19 August 2017

language of work or name

1 reference

1 August 2008

1 reference

Expert Review of Cardiovascular Therapy

19 August 2017

published in

1 reference

19 August 2017

volume

6

1 reference

19 August 2017

issue

7

1 reference

19 August 2017

page(s)

945-954

1 reference

Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Clinical outcome of mitral regurgitation due to flail leaflet

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Assessment of aortic stenosis by three-dimensional echocardiography: an accurate and novel approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Real-time three-dimensional echocardiography in aortic stenosis: a novel, simple, and reliable method to improve accuracy in area calculation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Hypercholesterolemic aortic-valve disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

C-reactive protein is increased in patients with degenerative aortic valvular stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Calcified rheumatic valve neoangiogenesis is associated with vascular endothelial growth factor expression and osteoblast-like bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Angiogenic activation of valvular endothelial cells in aortic valve stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Human Aortic Valve Calcification Is Associated With an Osteoblast Phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Can serum lipid and CRP levels predict the "severity" of aortic valve stenosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Diseases of Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Natriuretic peptides in patients with aortic stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Brain natriuretic peptide concentrations in patients with aortic stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

The effect of aortic valve replacement on N-terminal natriuretic propeptides in patients with aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Left atrium size and the risk of cardiovascular death in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

T lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Novel clinical markers of vascular wall inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Inflammatory bio-markers and cardiovascular risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Soluble CD40L and cardiovascular risk in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

C-reactive protein levels and outcomes after statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Is it time for medical therapy for aortic valve disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Association of Aortic-Valve Sclerosis with Cardiovascular Mortality and Morbidity in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

Association of Angiotensin-Converting Enzyme With Low-Density Lipoprotein in Aortic Valvular Lesions and in Human Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.945

21 January 2018

Identifiers

DOI

10.1586/14779072.6.7.945

1 reference

19 August 2017

1 reference